National Research (NASDAQ:NRC) Shares Pass Above 200-Day Moving Average – Here’s What Happened

National Research Corporation (NASDAQ:NRC)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $18.24 and traded as high as $21.82. National Research shares last traded at $21.19, with a volume of 142,811 shares changing hands.

Analyst Ratings Changes

A number of analysts have recently issued reports on NRC shares. Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, August 6th. Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Citizens Jmp lifted their price objective on shares of National Research from $23.00 to $26.00 and gave the company a “market outperform” rating in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $26.00.

National Research Stock Performance

The firm has a 50 day moving average of $20.63 and a 200-day moving average of $18.24. The company has a market cap of $482.07 million, a P/E ratio of 84.76 and a beta of 0.34. The company has a quick ratio of 0.65, a current ratio of 0.65 and a debt-to-equity ratio of 13.13.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.46. National Research had a return on equity of 164.26% and a net margin of 4.18%.The business had revenue of $35.39 million during the quarter, compared to analyst estimates of $34.90 million.

National Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Friday, September 25th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 25th. This represents a $0.64 annualized dividend and a dividend yield of 3.0%. National Research’s dividend payout ratio is 256.00%.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of NRC. Heartland Advisors Inc. boosted its position in National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after buying an additional 187,147 shares during the last quarter. AQR Capital Management LLC lifted its stake in National Research by 86.2% during the 2nd quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock valued at $3,383,000 after acquiring an additional 93,262 shares during the period. Fifth Third Bancorp acquired a new stake in National Research during the 1st quarter valued at approximately $1,531,000. Jane Street Group LLC lifted its stake in National Research by 394.2% during the 1st quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after acquiring an additional 41,806 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of National Research by 180.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 49,076 shares of the company’s stock valued at $627,000 after acquiring an additional 31,599 shares during the last quarter. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.